Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Sep 2025 is 2.46% vs -11.37% in Jun 2025
Standalone Net Profit
QoQ Growth in quarter ended Sep 2025 is -7.96% vs 158.78% in Jun 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Sep 2025 is -15.42% vs 62.18% in Jun 2025
Interest
QoQ Growth in quarter ended Sep 2025 is -5.49% vs 10.98% in Jun 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has fallen from Jun 2025
Compare Quarterly Results Of Bafna Pharma. With
Quarterly - Net Sales
QoQ Growth in quarter ended Sep 2025 is 2.46% vs -11.37% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -12.03% vs -0.88% in Sep 2024
Quarterly - Standalone Net Profit
QoQ Growth in quarter ended Sep 2025 is -7.96% vs 158.78% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 19.08% vs 5.65% in Sep 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Sep 2025 is -15.42% vs 62.18% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 12.93% vs -5.25% in Sep 2024
Quarterly - Interest
QoQ Growth in quarter ended Sep 2025 is -5.49% vs 10.98% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 38.71% vs 40.91% in Sep 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has fallen from Jun 2025
YoY Growth in quarter ended Sep 2025 has improved from Sep 2024






